Once-weekly administration of insulin in the real-world management of type 2 diabetes. A Delphi-like consensus

The advent of once-weekly insulin icodec therapy is an unprecedent breakthrough in diabetes care. Compared with once-daily insulin analogues, it offers a simplified, secure, enhanced, and sustained glycemic control, counteracting therapeutic inertia, expectedly improving adherence to insulin therapy. Insulin icodec can not only enable personalized treatment and positively impact the clinical outcome, but also improve patient satisfaction and overall quality of life.

Authors

Institutions

Publication Details

Journal
Acta Diabetologica
Published
2025-12-03
DOI
https://doi.org/10.1007/s00592-025-02619-8
Primary Topic
Diabetes Management and Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Once-weekly administration of insulin in the real-world management of type 2 diabetes. A Delphi-like consensus

Agostino Consoli, Raffaella Buzzetti, Enrico Torre, Roberto Trevisan et al.
Acta Diabetologica
Diabetes Management and Research
article

Once-weekly administration of insulin in the real-world management of type 2 diabetes. A Delphi-like consensus

Agostino Consoli, Raffaella Buzzetti, Enrico Torre, Roberto Trevisan, Cesare Berra, Gian Paolo Fadini, Giuseppina Tiziana Russo, Katherine Esposito, Concetta Irace, Edoardo Mannucci, Francesco Giorgino, Gianluca Perseghin, Paolo Di Bartolo, Sebastiano Bruno Solerte, Andrea Giaccari, Riccardo Candido, S. E. Oleandri
article en

Abstract

The advent of once-weekly insulin icodec therapy is an unprecedent breakthrough in diabetes care. Compared with once-daily insulin analogues, it offers a simplified, secure, enhanced, and sustained glycemic control, counteracting therapeutic inertia, expectedly improving adherence to insulin therapy. Insulin icodec can not only enable personalized treatment and positively impact the clinical outcome, but also improve patient satisfaction and overall quality of life.

Acta DiabetologicaVol. 63(2)
University of Padua (IT), Magna Graecia University (IT), University of Chieti-Pescara (IT), Ospedale Papa Giovanni XXIII (IT), Azienda Sanitaria Universitaria Integrata di Trieste (IT), University of Milano-Bicocca (IT), University of Genoa (IT), Sapienza University of Rome (IT)
Novo Nordisk, Università Cattolica del Sacro Cuore, Università degli Studi della Campania Luigi Vanvitelli
Openalex Percentile: Top 50%
Diabetes Management and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.